New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis

Atherosclerosis

Volumn 124, Issue 1, 1996, Pages 1-8

  Beisiegel, Ulrike ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Chylomicrons; Hepatic lipase; LDL receptor related protein; Lipoprotein lipase; Proteoglycans

Indexed keywords

CHYLOMICRON; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEOGLYCAN;

ATHEROGENESIS; ATHEROSCLEROSIS; CATABOLISM; HUMAN; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; REVIEW;

EID: 0030007773     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05792-7     Document Type: Short Survey

References (111)

1. Zilversmit DB. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ Res 33;1973:633.
2. Zilversmit DB. Atherogenic nature of triglycerides, post-prandial lipidemia and triglyceride-rich remnant lipoproteins. Clin Chem 1995;41:153.
3. Luoma J, Hiltunen T, Särkioja T, Moestrup SK, Gliemann J, Kodama T, Nikkari T, Ylä-Hertualla S. Expression of α2-macroglobulin receptor/low density lipoprotein receptor-related protein and the scavenger receptor in human atherosclerotic lesions. J Clin Invest 1994;93:2014.
4. Watanabe Y, Inaba T, Shimano H, Gotoda T, Yamamoto K, Mokuno H, Sato H, Yazaki Y, Yamada N. Induction of LDL receptor-related protein during the differentiation of monocyte-macrophages. Arterioscler Thromb 1994;14:1000.
5. Renier G, Lambert A. Lipoprotein lipase synergize with interferon-γ to induce macrophage nitric oxide synthetase mRNA expression and nitric oxide production. Arterioscler Thromb Vasc Biol 1995;15:392.
6. Inaba T, Kawamura M, Gotoda T, Harada K, Shimada M, Ohsuga J, Simano H, Akanuma Y, Yazaki Y, Yamada N. Effects of platelet-derived growth factor on the synthesis of lipoprotein lipase in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol. 1995;15:522.
7. Austin M. Plasma triglycerides and coronary heart disease. Arterioscler Thromb 1991;11:2.
8. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Post-prandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994;106:83.
9. Havel RJ. Post-prandial hyperlipidemia and remnant lipoproteins. Curr Opinion Lipidol 1994;5:102.
10. Olivecrona G, Olivecrona T. Triglyceride lipases and atherosclerosis. Curr Opinion Lipidol 1995;6:291.
11. Datta S, Luo C-C, Li W-H, van Tuinen P, Ledbetter DH, Brown MA, Chen S-H, Liu S-W, Chan L. Human hepatic lipase. J Biol Chem 1988;263:1107.
12. Kirchgessner TG, Chuat J-C, Heinzmann C, Etienne J, Guilhot S, Svenson K, Ameis D, Pilon CL, D'Auriol L, Andalibi A, Schotz MS, Galibert F, Lusis AJ. Organization of the human lipoprotein lipase gene and evaluation of the lipase gene family. Proc Natl Acad Sci USA 1989;86:9647.
13. Hide WA, Chan L, Li W-H. Structure and evolution of the lipase superfamily. J Lipid Res 1992;33:167.
14. Olivecrona T, Bengtsson-Olivecrona G. Lipases involved in lipoprotein metabolism. Curr Opin Lipidol 1990;1:116.
15. Hayden MS, Ma Y, Brunzell J, Henderson HE. Genetic variants affecting human lipoprotein and hepatic lipases. Curr Opin Lipidol 1991;2:104.
16. Kern PA. Lipoprotein lipase and hepatic lipase. Curr Opin Lipidol 1991;2:162.
17. Lalouel J-M, Wilson DE, Iverius P-H. Lipoprotein lipase and hepatic triglyceride lipase: molecular and genetic aspects. Curr Opin Lipidol 1992;3:86.
18. Olivecrona T, Bengtsson-Olivecrona G. Lipoprotein lipase and hepatic lipase. Curr Opin Lipidol 1993;4:187.
19. Korn ED. Clearing factor, a heparin-activated lipoprotein lipase. J Biol Chem 1955;215:15.
20. Östlund-Lindqvist A-M, Boberg J. Purification of salt-resistent lipase and lipoprotein lipase from human post-heparin plasma. FEBS Lett 1977;83:231.
21. Brunzell JD. Familial lipoprotein lipase deficiency and other cases of chylomicronemia syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, (eds), The Metabolic Basis of Inherited Disease I. McGraw Hill, 6th edition: 1989;1165.
22. Auwerx JH, Babirak SP, Fujimoto WY, Iverius P-H, Brunzell JD. Defective enzyme protein in lipoprotein lipase deficiency. Eur J Clin Invest 1989;19:433-437.
23. Eckel RH, Lipoprotein lipase - a multifunctional enzyme relevant to common metabolic diseases. New Engl J Med 1989;320:1060.
24. Eckel RH, Robbins RJ. Lipoprotein lipase is produced, regulated and functional in rat brain. Proc Natl Acad Sci USA 1984;81:7604.
25. Ranganathan G, Ong JM, Yukht A, Saghizadeh M, Simsolo RB, Pauer A, Kern PA. Tissue-specific expression of human lipoprotein lipase. J Biol Chem 1995;270:7149.
26. Ben-Zeev O, Lusis AJ, Laboeuf RC, Nikazy J, Schotz MC. Evidence for independent genetic regulation of heart and adipose lipoprotein lipase activity. J Biol Chem 1993;258:13632.
27. Enerbäck S, Ohlsson BG, Samuelsson L, Bjursell G. Characterization of the human lipoprotein lipase (LPL) promoter: evidence of two cis-regulatory regions, Lp-a and Lp-ß, of importance for the differentiation linked induction of the LPL gene during adipogenesis. Mol Cell Biol 1992;12:4622.
28. Currie RA, Eckel RH. Characterization of a high affinity octamer transcription factor binding site in the human lipoprotein lipase promoter. Arch Biochem Biophys 1992;298:630.
29. Doolittle MH, Ben-Zeev O, Elovson J, Martin D, Kirchgessner TG. The response of lipoprotein lipase to feeding and fasting. J Biol Chem 1990;265:4570.
30. Staels B, Auwerx J. Pertubation of developmental gene expression in rat liver by fibric acid derivates: lipoprotein lipase and α-fetoprotein as models. Development 1992;115:1035.
31. Hata A, Ridinger DN, Sutherland SD, Emi M, Kwong LK, Shuhua J, Lubbers A, Guy-Grand B, Basdevant A, Iverius P-H, Wilson DE, Lalouel J-M. Missense mutations in exon 5 of the human lipoprotein lipase gene. Inactivation correlates with loss of dimerization. J Biol Chem 1992;267:20132.
32. Peterson J, Fujimoto WY, Brunzel JD. Human lipoprotein lipase: relationship of activity, heparin affinity and conformation as studied with monoclonal antibodies. J Lipid Res 33:192;1165.
33. Bengtsson G, Olivecrona T. Lipoprotein lipase: some effects of activator proteins. Eur J Biochem 1980;106:549.
34. Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, Bisgaier CL. Lipoprotein apo C-II activation of lipoprotein lipase. J Biol Chem 1990;265:4266.
35. Santamarina-Fojo S, Genetic dyslipoproteinemias: role of lipoprotein lipase and apolipoprotein C-II. Curr Opin Lipidol 1992;3:186.
36. Wang C-S, McConathy WJ, Klör HU, Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest 1985;76:384.
37. Wallinder L, Peterson J, Olivecrona T, Bengtsson-Olivecrona G. Hepatic and extrahepatic uptake of intravenously injected lipoprotein lipase. Biochim Biophys Acta 1984;795:513.
38. Vilaro S, Llobera M, Bengtsson-Olivecrona G, Olivecrona T. Lipoprotein lipase uptake in the liver: localization, turnover and metabolic role. Am Physiol Soc, 1988.
39. Saxena U, Klein MG, Goldberg IJ. Metabolism of endothelial cell-bound lipoprotein lipase. J Biol Chem 1989;265:12880.
40. Kirchgessner TG, Svenson KL, Lusis AJ, Schotz MC. The sequence of cDNA encoding lipoprotein lipase. J Biol Chem 1987;262:8463.
41. van Tilbeurgh H, Roussel A, Lalouel J-M, Cambillau C. Lipoprotein lipase. Molecular model based on the pancreatic lipase x-ray structure: consequences for heparin binding and catalysis. J Biol Chem 1994;269:4626.
42. Wong H, Davies RC, Thuren T, Goers JW, Nikazy J, Waite M, Schotz MC. Lipoprotein lipase domain function. J Biol Chem 1994;269:10319.
43. Faustinella F, Smith LC, Chan L. Functional topology of a surface loop shielding the catalytic center in lipoprotein lipase. Biochemistry 1992;31:7219.
44. Dugi K, Dichek HL, Talley GD, Brewer HB, Santamarina-Fojo S. Human lipoprotein lipase: the loop covering the catalytic site is essential for interaction with lipid substrates. J Biol Chem 1992;267:25086.
45. Nijmmegen) resulting in loss of catalytic activity. Eur J Biochem 1992;208:267.
46. Faustinella F, Chang A, van Biervliet JP, Rosseneu M, Vinaimont N, Smith LC, Chen S-H, Chan L. Catalytic triad residue mutation (Asp156→ Gly) causing familial lipoprotein lipase deficiency. J Biol Chem 1991;266:14418.
47. Emmerich J, Beg OU, Peterson J, Previato L, Brunzell JD, Brewer HB, Santamarina-Fojo S. Human lipoprotein lipase. Analysis of the catalytic triad by site-directed mutagenesis of Ser-132, Asp-156 and His-241. J Biol Chem 1992;267:4161.
48. Henderson HE, Ma Y, Liu M-S, Clark-Lewis I, Maeder DL, Kastelein JJP, Brunzell JD, Hayden MR. Structure-function relationships of lipoprotein lipase: mutation analysis and mutagenesis of the loop region. J Lipid Res 1993;34:1593.
49. Liu M-S, Ma Y, Hayden MR, Brunzell JD. Mapping of the epitope on lipoprotein lipase recognized by a monoclonal antibody (5D2) which inhibits lipase activity. Biochim Biophys Acta 1992;1128:113.
50. Bengtsson G, Olivecrona T. Interaction of lipoprotein lipase with heparin-sepharose. Evaluation of conditions for affinity binding. Biochem J 1977;167:109.
51. Hata L, Ridinger DN, Sutherland S, Emi B, Shuhua Z, Myers RL, Ren K, Cheng T, Inoue I, Wilson DE, Iverius P-H, Lalouel J. Binding of lipoprotein lipase to heparin - identification of 5 critical residues in 2 distinct segments of the amino terminal domain. J Biol Chem 1992;268:8447.
52. Ma Y, Henderson HE, Liu M-S, Zhang H, Forsythe IJ, Clarke-Lewis I, Hayden MR, Brunzell JD. Mutagenesis in four candidate heparin binding regions (residues 279-282, 291-304, 390-393 and 439-448) and identification of residues effecting heparin binding of human lipoprotein lipase. J Lipid Res 1994;35:2049.
53. Lookene A, Bengtson-Olivecrona G. Chymotryptic cleavage of lipoprotein lipase. Identification of cleavage sites and functional studies on the truncated molecule. Eur J Biochem 1993;213:185.
54. Ma Y, Ooi TC, Liu M-S, Zhang H, McPherson R, Edwards AL, Forsythe IJ, Frohlich J, Brunzell JD, Hayden MR. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E-2 isoform. J Lipid Res 1994;35:1066.
55. Mailly F, Tugrul Y, Reymer PWA, Bruin T, Seed BF, Groenemeyer A, Asplund-Carlson D, Vallance AF, Winder GJ, Miller JJP, Kastelein A, Hamsten G, Olivecrona SE, Humphries, and PJ, Talmud. A common variant in the gene for lipoprotein lipase (Asp9→Asn). Arterioscler Thromb Vasc Biol 1995;15:468.
56. Minnich A, Kessling A, Roy M, Giry C, DeLangavant G, La vigne J, Lussier-Cacan S, Davignon J. Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients from French Canadian descent. J Lipid Res 1995;36:117.
57. Yang W-S, Nevin DN, Peng R, Brunzell JD, Deeb SS. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity. Proc Natl Acad Sci USA 1995;92:4462.
58. Liu M-S, Jirik FR, Laboeuf RC, Henderson H, Castellani LW, Lusis AJ, Ma Y, Forsythe IJ, Zhang H, Kirk E, Brunzell JD, Hayden MR. Alteration of lipid profiles in plasma of transgenic mice expressing human lipoprotein lipase. J Biol Chem 1994;269:11417.
59. Zsigmond E, Scheffler E, Forte TM, Potenz R, Wu W, Chan L. Transgenic mice expressing human lipoprotein lipase driven by mouse metallothionein promoter. J Biol Chem 1994;269:18757.
60. Jansen H, van Tol A. Hülsmann WC. On the metabolic function of heparin-releasable liver lipase. Biochem Biophys Res Comm 1980;92:53.
61. Jensen GL, Daggy B, Besadoun A. Triacylglycerol lipase, monoacylglycerol lipase and phospholipase activities of highly purified rat hepatic lipase. Biochim Biophys Acta 1982;710:464.
62. Kuusi T, Nikkilä, EA, Taskinen M-R, Somerharju P, Ehnholm C. Human post-heparin plasma hepatic lipase activity against triacylglycerol and phospholipid substrates. Clin Chim Acta 1982;122:39.
63. Laboda H, Glick JM, Phillips MC. Hydrolysis of lipid monolayers and the substrate specificity of hepatic lipase. Biochim Biophys Acta 1986;876:233.
64. Ameis D, Greten H, Schotz MC. Hepatic and plasma lipases. In: Seminars in Liver Disease. Thieme Med. Publ., New York. 1992;12:397.
65. Doolittle MH, Wong H, Davies RC, Schotz MC. Synthesis of hepatic lipase in liver and extrahepatic tissues. J Lipid Res 1987;28:1326.
66. Verhoeven AJ, Carling D, Jansen H. Hepatic lipase gene is transcribed in rat adrenals into a truncated mRNA. J Lipid Res 1994;35:966.
67. Datta S, Luo C-C, Li W-H, vanTuinen P, Ledbetter DH, Brown MA, Chen Liu S-H, S, Chan L. Human hepatic lipase, cloned cDNA sequence, restriction enzyme fragment length polymorphism, chromosomal location and evolutionary relationships with lipoprotein lipase and pancreatic lipase. J Biol Chem 1988;263:1107.
68. Ameis D, Stahnke G, Kobayashi J, McLean J, Lee G, Büscher M, Schotz MC, Will H. Isolation and characterization of the human hepatic lipase gene. J Biol Chem 1990;265:6552.
69. Hegele RA, Little JA, Vezina C, Maguire GF, Tu L, Wolever TS, Jenkins DJA, Connelly PW. Hepatic lipase deficiency. Clinical, biochemical and molecular genetic characteristics. Arterioscler Thromb 1993;13:720.
70. Carlson LA, Holmquist L, Nilsson-Ehle P. Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-α-triglyceridemia. Acta Med Scand 1986;219:435.
71. Breckenridge WC, Little JA, Alaupovic P, Wang CS, Kuksis A, Kakis G, Lindgren F, Gardiner G. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis 1982;45:161.
72. Demant T, Carlson LA, Holmquist L, Karpe F, Nilsson-Ehle P, Packard CJ, Shepherd J. Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res 1988;29:1603.
73. Auwerx JH, Marzetta CA, Hokanson JE, Brunzell JD. Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis 1989;9:319.
74. Fan J, Wang J, Bensadoun A, Lauer SJ, Dang Q, Mahley RW, Taylor JM. Over-expression of hepatic lipase in transgenic rabbit leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci USA 1994;91:8724.
75. Durstenfeld A, Ben-Zeev O, Reue K., Stahnke G, Doolittle MH. Molecular characterization of human hepatic lipase. In vitro expression of two naturally occurring mutations. Arterioscler Thromb 1994;14:381.
76. Homanics GE, deSilva HV, Osada J, Zhang SH, Wong H, Borensztajn J, Maeda N. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J Biol Chem 1995;270:2974.
77. Davies RC, Stahnke G, Wong H, Doolittle MH, Ameis D, Will H, Schotz MC. Hepatic lipase: site directed mutagenesis of a serine residue important for catalytic activity. J Biol Chem 1990;265:6291.
78. Derewenda ZS, Cambillau C. Effects of gene mutations in lipoprotein and hepatic lipase as interpreted by a molecular model of the pancreatic triglyceride lipase. J Biol Chem 1991;266:23112.
79. Davies RC, Wong H, Nikazy J, Wang K, Han Q, Schotz MC. Chimeras of hepatic and lipoprotein lipase. Domain localization of emzyme-specific properties. J Biol Chem 1992;267:21499.
80. Felts JM, Tajura H, Crane RT. The mechanism of assimilation of constituents of chylomicrons, very low density lipoproteins and remnants - a new theory. Biochem Biophys Res Comm 1975;66:1476.
81. Cooper AD, The metabolism of chylomicron remnants by isolated perfused rat liver. Biochem Biophys Acta 1977;488:464.
82. Borensztajn J, Getz G, Kotlar TJ. Uptake of chylomicron remnants by the liver: further evidence for the modulating role of phospholipids. J Lipid Res 1988;29:1087.
83. Aviram M, Bierman EL, Chait A. Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells. J Biol Chem 1988;263:15416.
84. Evans AJ, Sawyez CG, Wolfe BM, Huff MW. Lipolysis is a pre-requisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic very low density lipoproteins. J Biol Chem 1992;267:10743.
85. Sehayek E, Lewin-Velvert U, Chajek-Shaul T, Eisenberg S. Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein. J Clin Invest 1991;88:553.
86. Brasaemle DL, Cornely-Moss K, Bensadoun A. Hepatic lipase treatment of chylomicron remnants exposure of apolipoprotein E. J Lipid Res 1993;34:455.
87. Chajek-Shaul T, Friedman G, Stein O, Olivecrona T, Stein Y. Binding of lipoprotein lipase to the cell surface is essential for the transmembrane transport of chylomicron cholesteryl ester. Biochem Biophys Acta 1982;712:200.
88. Goldberg IJ, Kandel JJ, Blum CB, Ginsberg HN. Association of plasma lipoproteins with post-heparin lipase activities. J Clin Invest 1986;78:1523.
89. Villela E, Joven J, Fernandez M, Vilar S, Brunzell JD, Olivecrona T, Olivecrona G. Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins. J Lipid Res 1993;34:1555.
90. Beisiegel U, Weber W, Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related prrotein. Proc Natl Acad Sci USA 1991;88:8342.
91. Eisenberg S, Sehayek E, Olivecrona T, Vlodavsky I. Lipoprotein lipase enhances binding of lipoproteins to heparin sulfate on cell surfaces and extracellular matrix. J Clin Invest 1992;90:2013.
92. Sheng-Zhong J, Sanan DA, Mahley RW. Intravenous heparinase inhibits lipoproteins clearance from the plasma and uptake by the liver: in vivo role of heparin sulfate proteoglycans. J Lipid Res 1995;36:583.
93. Chappell DA, Fry GL, Waknitz MA, Iverius P-H, Williams SE, Strickland DK. The low density lipoprotein receptor-related protein/α2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase. J Biol Chem 1992;267:25764.
94. Nykjaer A, Bengtsson-Olivecrona G, Lookene A, Moestrup SK, Petersen CM, Weber W, Beisiegel U, Gliemann J. The α2-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and β-migrating very low density lipoprotein associated with the lipase. J Biol Chem 1993;268:15048.
95. Rumsey SC, Obunike JC, Arad Y, Deckelbaum RJ, Goldberg I. Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J Clin Invest 1992;90:1504.
96. Mulder M, Lombardi P, Jansen H, van Berkel TJC, Frants RR, Havekes LM. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparin sulfate proteoglycans via lipoprotein lipase. J Biol Chem 1993;268:9369.
97. Beisiegel U, Krapp A, Weber W, Olivecrona G. The role of α2 M receptor/LRP in chylomicron remnant metabolism. In: Borth W, Feiman RD, Gonias SL, Quigle JP, Strickland DK, (eds), Biology of α2-Macroglobulin, its Receptors and Related Proteins. The Annals of the New York Academy of Sciences, New York. 1994;737:53.
98. Obunike JC, Edwards IJ, Rumsey SC, Curtiss LK, Wagner WD, Deckelbaum RJ, Goldberg IJ. Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins. J Biol Chem 1994;269:13129.
99. Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, Miyabo S, Yamamoto T, Nakai T. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J Biol Chem 1995;270:15747.
100. Williams SE, Inoue I, Tran H, Fray GL, Pladet MW, Iverius P-H, Lalouel J-M, Chappell DA, Strickland DK. The carboxy-terminal domain of lipoprotein lipase binds to the low density lipoprotein receptor-related protein/ α2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoproteins to LRP. J Biol Chem 1994;269:8653.
101. Nykjaer A, Nielson M, Lookene A, Meyer N, Roigaard H, Etzerodt M, Beisiegel U, Olivecrona G, Gliemann J. A carboxy-terminal fragment of lipoprotein lipase binds to the low density lipoprotein receptor-related protein and inhibits lipase-mediated uptake of lipoprotein in cells. J Biol Chem 1994;269:31747-31755.
102. Sivaram P, Choi SY, Curtiss LK, Goldberg IJ. An amino-terminal fragment of apolipoprotein B binds to lipoprotein lipase and may facilitate its binding to endothelial cells. J Biol Chem 1994;269:9409.
103. Krapp A, Zhang H, Ginzinger D, Liu M-S, Lindberg A, Olivecrona G, Hayden MS, Beisiegel U. Structural features in lipoprotein lipase necessary for the mediation of lipoprotein uptake into cells. J Lipid Res 1995;36: in press.
104. Skottova N, Savonen R, Lookene A, Hultin M, Olivecrona G. Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by perfused rat liver. J Lipid Res 1995;36:1334.
105. Coleman T, Seip RL, Gimble JM, Lee D, Maeda N, Semenkovich CF. COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity. J Biol Chem 1995;270:12518.
106. Shafi S, Brady SE, Bensadoun A, Havel RJ. Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. J Lipid Res 1994;35:709.
107. Diard P, Malewiak M-I, Lagrange D, Griglio S. Hepatic lipase may act as a ligand in the uptake of artificial cylomicron remnant-like particles by isolated rat hepatocytes. Biochem J 1994;299:889.
108. Zhong-Sheng J, Lauer SJ, Fazio S, Bensadoun A, Taylor JM, Mahley RW. Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J Biol Chem 1994;269:13429.
109. Fan J, Wang J, Bensadoun A, Lauer SJ, Dang Q, Mahley RW, Taylor JM. Over-expression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci USA 1994;91:8724.
110. O'Brien KD, Gordon D, Deeb S, Ferguson M, Chait A. Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J Clin Invest 1992;89:1544.
111. Luoma J, Hiltunen T, Särkioja T, Moestrup SK, Gliemann J, Kodama T, Nikkari T, Ylä-Herttuala S. Expression of α2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J Clin Invest 1994;93:2014.